The legacy of Viagra and the medicinal industry presents a challenging picture for careful investors. Initially, copyright's remarkable drug revolutionized the treatment of erectile dysfunction, generating massive profits and defining the current pharmaceutical landscape. However, exclusive rights expiration and the rise of generic versions have co